Chang Dong Liu

Chang Dong Liu

Plus aucun poste en cours

62 ans
Health Technology
Consumer Services

Profil

Chang Dong Liu worked as Chief Medical Officer & Senior Vice President at Qilu Pharmaceutical Co., Ltd.
from 2015 to 2016.
He then worked as Senior Vice President-Clinical Development at Bio-Thera Solutions, Ltd.
in 2014-2015.
From 2016 to 2018, he served as Vice President-Clinical Development at Livzon MABPharm Inc. Currently, he is the Chief Scientific Officer at Ocumension Therapeutics.
Liu received his undergraduate and graduate degrees from Tongji Medical College of Huazhong University of Sci & Tech in 1983 and 1988, respectively.

Anciens postes connus de Chang Dong Liu

SociétésPosteFin
Corporate Officer/Principal 01/06/2018
Chief Tech/Sci/R&D Officer 01/07/2016
BIO-THERA SOLUTIONS, LTD. Corporate Officer/Principal 01/12/2015
OCUMENSION THERAPEUTICS Chief Tech/Sci/R&D Officer -
Voir l'expérience en détail de Chang Dong Liu

Formation de Chang Dong Liu

Tongji Medical College of Huazhong University of Sci & Tech Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Chang Dong Liu

Relations

13

Relations au 1er degré

5

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
BIO-THERA SOLUTIONS, LTD.

Health Technology

OCUMENSION THERAPEUTICS

Health Technology

Entreprise privées2

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Chang Dong Liu